Original Research

Accepted on 04 Oct 2024

Pro-inflammatory macrophages suppress HIV replication in humanized mice and ex vivo co-cultures

in Viral Immunology

Luca Baroncini
Christina Muller
Nicole Patrizia Kadzioch
Rebekka Wolfensberger
Doris Russenberger
Simon Bredl
Tafadzwa Mlambo
Roberto Federico Speck

Frontiers in Immunology

doi 10.3389/fimmu.2024.1439328

Case Report

Published on 04 Oct 2024

Case report: Rare Guillain-Barré syndrome variants and mild encephalitis/encephalopathy with a reversible splenial lesion as the para-infectious manifestations of SARS-CoV-2 infection

in Viral Immunology

Wei Si
Yuanrui Li
Ganqin Du

Frontiers in Immunology

doi 10.3389/fimmu.2024.1458231

328 views

Original Research

Published on 04 Oct 2024

Systemic increase in IL-26 is associated with severe COVID-19 and comorbid obstructive lung disease

in Viral Immunology

Eduardo I. Cardenas
Josefina Robertson
Salvia Misaghian
Jermaine Brown
Mingyue Wang
Martin Stengelin
George Sigal
Jacob Wohlstadter
Magnus Gisslén
Anders Lindén

Frontiers in Immunology

doi 10.3389/fimmu.2024.1434186

227 views

Original Research

Accepted on 03 Oct 2024

BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis

in Viral Immunology

Faith Jessica Paran
Rieko Oyama
Abdullah Khasawneh
Ai Tomohiko
Hendra Saputra Ismanto
Aalaa Alrahman Sherif
Dianita Susilo Saputri
Chikako Ono
Mizue Saita
Satomi Takei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1405013

Perspective

Published on 03 Oct 2024

Exploring pathogen population density as a metric for understanding post-COVID infectious disease surges

in Viral Immunology

Luwen Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1459628

104 views

Review

Accepted on 02 Oct 2024

Contribution of immunoglobulin products in influencing seasonal influenza infectivity and severity in antibody immune deficiency patients receiving replacement immunoglobulin therapy

in Viral Immunology

Mark Ballow
Raúl Ortiz-de-Lejarazu
Isabella Quinti
Matthew Miller
Klaus Warnatz

Frontiers in Immunology

doi 10.3389/fimmu.2024.1452106

Original Research

Published on 01 Oct 2024

Challenging boundaries: is cross-protection evaluation necessary for African swine fever vaccine development? A case of oral vaccination in wild boar

in Viral Immunology

Estefanía Cadenas-Fernández
Sandra Barroso-Arévalo
Aleksandra Kosowska
Marta Díaz-Frutos
Carmina Gallardo
Antonio Rodríguez-Bertos
Jaime Bosch
Jose M. Sánchez-Vizcaíno
Jose A. Barasona

Frontiers in Immunology

doi 10.3389/fimmu.2024.1388812

452 views

Original Research

Published on 01 Oct 2024

Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48

in Viral Immunology

Wenqi Wang
Qiushi Jin
Ruixue Liu
Wentao Zeng
Pengfei Zhu
Tingting Li
Tiecheng Wang
Haiyang Xiang
Hang Zhang
Qin Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1427284

101 views

Original Research

Published on 30 Sep 2024

Development of a COVID-19 early risk assessment system based on multiple machine learning algorithms and routine blood tests: a real-world study

in Viral Immunology

Qiangqiang Qin
Qingxuan Li
Guiyin Zhu
Haiyang Yu
Mingyan Peng
Shuang Wu
Xue Xu
Wen Gu
Xuejun Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430899

258 views

Brief Research Report

Published on 30 Sep 2024

Reduced antiviral gene expression and elevated CXCL8 expression in peripheral blood are associated with severe hypoxemia in RSV-infected children

in Viral Immunology

Carlos Pita-Martínez
Carmen Goez-Sanz
Ana Virseda-Berdices
Alejandro Gonzalez-Praetorius
Esther Mazario-Martín
María Rodriguez-Mesa
Marta Quero-Delgado
Vanesa Matías
Isidoro Martínez
Salvador Resino

Frontiers in Immunology

doi 10.3389/fimmu.2024.1438630

156 views

Original Research

Published on 27 Sep 2024

Seroprevalence of binding and neutralizing antibodies against 18 adeno-associated virus types in patients with neuromuscular disorders

in Viral Immunology

Xiaoyan Wang
Patrick Julian Klann
Ellen Wiedtke
Yumi Sano
Nico Fischer
Lisa Schiller
Anna Elfert
Anne-Katrin Güttsches
Ute Weyen
Dirk Grimm

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450858

414 views

Original Research

Published on 26 Sep 2024

Exploring common pathogenic association between Epstein Barr virus infection and long-COVID by integrating RNA-Seq and molecular dynamics simulations

in Viral Immunology

Ayesha Kanwal
Zhiyong Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435170

492 views

Original Research

Accepted on 25 Sep 2024

Acute-Phase Innate Immune Responses in SIVmac239-Infected Mamu-B*08+ Indian Rhesus Macaques May Contribute to the Establishment of Elite Control

in Viral Immunology

Brandon Charles Rosen
Kaitlin Sawatzki
Michael Ricciardi
Elise Smith
Inah Golez
Jack T Mauter
Nuria Pedreno-Lopez
Aaron Yrizarry-Medina
Kim L Weisgrau
Logan J Vosler

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478063

Original Research

Accepted on 25 Sep 2024

Comparison of HBV-specific T cell reactivity across the pregnant, postpartum and non-pregnant women with chronic HBV infection

in Viral Immunology

Chuanlai Shen
Genju Wang
Fangping Yue
Ziyue Zhang
Yandan Wu
Ruixue Ji
Guanlun Zhou
Ying Ji

Frontiers in Immunology

doi 10.3389/fimmu.2024.1461767

Brief Research Report

Published on 25 Sep 2024

Exploring the role of galectin-9 and artemin as biomarkers in long COVID with chronic fatigue syndrome: links to inflammation and cognitive function

in Viral Immunology

Shokrollah Elahi
Maryam Rezaeifar
Mohammed Osman
Shima Shahbaz

Frontiers in Immunology

doi 10.3389/fimmu.2024.1443363

803 views

Brief Research Report

Accepted on 24 Sep 2024

Inhaled GM-CSF administered during ongoing pneumovirus infection alters myeloid and CD8 T cell immunity without affecting disease outcome

in Viral Immunology

Nincy Debeuf
Julie Deckers
Sahine Lameire
Cedric Bosteels
Hamida Hammad
Bart N. Lambrecht

Frontiers in Immunology

doi 10.3389/fimmu.2024.1439789

117 views

Navigation group

Articles

Pro-inflammatory macrophages suppress HIV replication in humanized mice and ex vivo co-cultures

Case report: Rare Guillain-Barré syndrome variants and mild encephalitis/encephalopathy with a reversible splenial lesion as the para-infectious manifestations of SARS-CoV-2 infection

Systemic increase in IL-26 is associated with severe COVID-19 and comorbid obstructive lung disease

BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis

Exploring pathogen population density as a metric for understanding post-COVID infectious disease surges

Contribution of immunoglobulin products in influencing seasonal influenza infectivity and severity in antibody immune deficiency patients receiving replacement immunoglobulin therapy

Challenging boundaries: is cross-protection evaluation necessary for African swine fever vaccine development? A case of oral vaccination in wild boar

Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48

Development of a COVID-19 early risk assessment system based on multiple machine learning algorithms and routine blood tests: a real-world study

Reduced antiviral gene expression and elevated CXCL8 expression in peripheral blood are associated with severe hypoxemia in RSV-infected children

Seroprevalence of binding and neutralizing antibodies against 18 adeno-associated virus types in patients with neuromuscular disorders

Exploring common pathogenic association between Epstein Barr virus infection and long-COVID by integrating RNA-Seq and molecular dynamics simulations

Acute-Phase Innate Immune Responses in SIVmac239-Infected Mamu-B*08+ Indian Rhesus Macaques May Contribute to the Establishment of Elite Control

Comparison of HBV-specific T cell reactivity across the pregnant, postpartum and non-pregnant women with chronic HBV infection

Exploring the role of galectin-9 and artemin as biomarkers in long COVID with chronic fatigue syndrome: links to inflammation and cognitive function

Inhaled GM-CSF administered during ongoing pneumovirus infection alters myeloid and CD8 T cell immunity without affecting disease outcome